Caladrius Biosciences
Total Awards:
2
Award Value:
$11,175,946
Institution type:
For profit
Short Name:
Caladrius Biosciences
Awards to the Institution
| Program Type | Investigator | Grant Title | Award Value |
|---|---|---|---|
| Clinical Trial Stage Projects | Dr. William Sietsema | Phase 2 Safety and Efficacy Study of CLBS03 Autologous T-Regulatory Cells in Adolescents with Recent Onset Type 1 Diabetes Mellitus | $8,175,946 |
| Clinical Trial Stage Projects | Robert Dillman | Tumor stem cell-targeted immunotherapy for metastatic melanoma –a randomized phase 3 clinical trial. | $3,000,000 |
| Total: $11,175,946.00 |
